Belinda Lennox
Contact information
+44 (0)1865 613145
Fax +44 (0)1865 793101
Jane Hainsworth
jane.hainsworth@psych.ox.ac.uk
Further information and support
For further information about research into autoimmune psychosis please visit
www.antibodymediatedpsychosis.org/ produced by the McPin Foundation.
Belinda Lennox
BMedSci BM BS DM FRCPsych
Associate Professor and Clinical Senior Lecturer
- Honorary Consultant Psychiatrist
- Clinical Director NIHR CRN Thames Valley and South Midlands
- Deputy Director NIHR CLAHRC Oxford
- Clinical Lead Early Intervention Psychosis NHS England South
early psychosis, neuroimmunology
My research is on the causes and treatment of psychotic illness.
Psychotic illnesses such as schizophrenia and bipolar disorder are serious mental illnesses of unknown cause. There is an urgent need to discover the basis of these illnesses, and to develop new treatments
I am exploring the neuro-immunological basis of psychotic disorders. We have described the prevalence of antibodies against the NMDA receptor, and other neuronal targets, in people with a first episode of psychosis. We are now setting up a clinical trial to see whether immunotherapy is an effective treatment for psychosis, in people with these antibodies
I run a joint psychiatry- neuroimmunology clinic with Dr Camilla Buckley at Oxford University Hospitals NHS Trust for treating people with psychosis and antibodies, run alongside Professor Angela Vincent's neuroimmunology laboratory. Together we collaborate with academic groups and clinicians from across the UK and internationally to advance our understanding of these disorders and to treat patients with the best evidence based treatments.
I am academic lead for the Early Intervention in psychosis service for Oxford Health NHS FT and am leading the evaluation and implementation of early intervention in psychosis services across the Thames Valley through the NIHR CLAHRC for Oxford and Oxford AHSN Early Intervention in Mental Health Network.
Key publications
-
Journal article
Zandi MS. et al, (2011), J Neurol, 258, 686 - 688
-
Journal article
Zandi MS. et al, (2014), Schizophr Res, 160, 193 - 195
-
Journal article
Lennox B. et al, (2017), The Lancet Psychiatry
-
Journal article
Al-Diwani AAJ. et al, (2017), Immunology, 152, 388 - 401
-
Economic impact of Early Intervention in Psychosis
services: results from a longitudinal retrospective controlled
study in England
Journal article
Tsiachristas A. et al, (2016), BMJ Open
Recent publications
-
Bullying Victimisation and Risk of Psychotic Phenomena
Conference paper
Broome M. et al, (2018), EARLY INTERVENTION IN PSYCHIATRY, 12, 83 - 83
-
Journal article
Maxwell S. et al, (2018), BJPsych Bull, 1 - 5
-
Journal article
Tomlinson A. et al, (2018), The Lancet Psychiatry, 5, 617 - 617
-
Journal article
Pollak TA. and Lennox BR., (2018), BJPsych Open, 4, 262 - 264
-
DO NMDAR ANTIBODIES CAUSE SCHIZOPHRENIA?
Conference paper
Lennox B., (2018), SCHIZOPHRENIA BULLETIN, 44, S60 - S60